Stereotaxis Crecimiento futuro
Future controles de criterios 2/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Stereotaxis de 30.2% y 34.3% respectivamente, mientras que el BPA crecerá en un 32.4% al año.
Información clave
32.1%
Tasa de crecimiento de los beneficios
33.6%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Medical Equipment | 16.9% |
| Tasa de crecimiento de los ingresos | 37.5% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | 14 May 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
US$9.33 - That's What Analysts Think Stereotaxis, Inc. (NYSEMKT:STXS) Is Worth After These Results
Feb 28
Is Stereotaxis (NYSEMKT:STXS) A Risky Investment?
Jan 28
Investors Who Bought Stereotaxis (NYSEMKT:STXS) Shares Five Years Ago Are Now Up 597%
Dec 24What Kind Of Investors Own Most Of Stereotaxis, Inc. (NYSEMKT:STXS)?
Nov 19Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2026 | 82 | -6 | N/A | N/A | 2 |
| 12/31/2025 | 44 | -16 | N/A | N/A | 4 |
| 12/31/2024 | 30 | -20 | N/A | N/A | 1 |
| 3/31/2024 | 27 | -21 | N/A | N/A | N/A |
| 12/31/2023 | 27 | -22 | -10 | -9 | N/A |
| 9/30/2023 | 30 | -21 | -10 | -9 | N/A |
| 6/30/2023 | 29 | -21 | -12 | -11 | N/A |
| 3/31/2023 | 28 | -21 | -11 | -9 | N/A |
| 12/31/2022 | 28 | -20 | -11 | -8 | N/A |
| 9/30/2022 | 29 | -19 | -10 | -7 | N/A |
| 6/30/2022 | 31 | -19 | -9 | -6 | N/A |
| 3/31/2022 | 33 | -15 | -7 | -5 | N/A |
| 12/31/2021 | 35 | -12 | -4 | -3 | N/A |
| 9/30/2021 | 34 | -10 | -2 | -1 | N/A |
| 6/30/2021 | 33 | -7 | -1 | 0 | N/A |
| 3/31/2021 | 29 | -8 | -2 | -2 | N/A |
| 12/31/2020 | 27 | -8 | -4 | -4 | N/A |
| 9/30/2020 | 27 | -8 | -6 | -6 | N/A |
| 6/30/2020 | 26 | -6 | -6 | -6 | N/A |
| 3/31/2020 | 28 | -6 | -5 | -5 | N/A |
| 12/31/2019 | 29 | -6 | -5 | -5 | N/A |
| 9/30/2019 | 29 | -6 | -4 | -3 | N/A |
| 6/30/2019 | 29 | -6 | -4 | -3 | N/A |
| 3/31/2019 | 29 | -4 | -3 | -2 | N/A |
| 12/31/2018 | 29 | -1 | -3 | -3 | N/A |
| 9/30/2018 | 30 | -3 | -3 | -3 | N/A |
| 6/30/2018 | 30 | -7 | -3 | -3 | N/A |
| 3/31/2018 | 31 | -7 | -4 | -4 | N/A |
| 12/31/2017 | 31 | -7 | N/A | -5 | N/A |
| 9/30/2017 | 31 | 1 | N/A | -4 | N/A |
| 6/30/2017 | 31 | -7 | N/A | -5 | N/A |
| 3/31/2017 | 30 | -9 | N/A | -5 | N/A |
| 12/31/2016 | 32 | -12 | N/A | -7 | N/A |
| 9/30/2016 | 34 | -19 | N/A | -5 | N/A |
| 6/30/2016 | 35 | -7 | N/A | -3 | N/A |
| 3/31/2016 | 37 | -6 | N/A | -3 | N/A |
| 12/31/2015 | 38 | -7 | N/A | -3 | N/A |
| 9/30/2015 | 38 | -5 | N/A | -6 | N/A |
| 6/30/2015 | 38 | -4 | N/A | -8 | N/A |
| 3/31/2015 | 36 | -4 | N/A | -10 | N/A |
| 12/31/2014 | 35 | -5 | N/A | -9 | N/A |
| 9/30/2014 | 34 | -10 | N/A | -9 | N/A |
| 6/30/2014 | 36 | -67 | N/A | -8 | N/A |
| 3/31/2014 | 38 | -68 | N/A | -8 | N/A |
| 12/31/2013 | 38 | -69 | N/A | -6 | N/A |
| 9/30/2013 | 41 | -69 | N/A | -5 | N/A |
| 6/30/2013 | 42 | -14 | N/A | -7 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: STXS is forecast to remain unprofitable over the next 3 years.
Beneficios vs. Mercado: STXS is forecast to remain unprofitable over the next 3 years.
Beneficios de alto crecimiento: STXS is forecast to remain unprofitable over the next 3 years.
Ingresos vs. Mercado: STXS's revenue (37.5% per year) is forecast to grow faster than the US market (8.4% per year).
Ingresos de alto crecimiento: STXS's revenue (37.5% per year) is forecast to grow faster than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de STXS se prevé que sea elevada dentro de 3 años.